Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial

BACKGROUND: The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum malaria. METHODOLOGY/PRINCIPAL FINDINGS: A Phase 1 double blind randomized controlled dose escalation trial was conducted in Bandiagara,...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Thera, Mahamadou A., Doumbo, Ogobara K., Coulibaly, Drissa, Laurens, Matthew B., Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Sissoko, Mady, Diallo, Dapa A., Diarra, Issa, Kouriba, Bourema, Daou, Modibo, Dolo, Amagana, Baby, Mounirou, Sissoko, Mahamadou S., Sagara, Issaka, Niangaly, Amadou, Traore, Idrissa, Olotu, Ally, Godeaux, Olivier, Leach, Amanda, Dubois, Marie-Claude, Ballou, W. Ripley, Cohen, Joe, Thompson, Darby, Dube, Tina, Soisson, Lorraine, Diggs, Carter L., Takala, Shannon L., Lyke, Kirsten E., House, Brent, Lanar, David E., Dutta, Sheetij, Heppner, D. Gray, Plowe, Christopher V.
Format: Artigo
Język:Inglês
Wydane: Public Library of Science 2010
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2816207/
https://ncbi.nlm.nih.gov/pubmed/20140214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0009041
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy